Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A prospective study of shortened vitamin supplementation prior to cisplatin-pemetrexed therapy for non-small cell lung cancer.
Takagi Y, Hosomi Y, Sunami K, Nakahara Y, Okuma Y, Yomota M, Shimokawa T, Nagamata M, Iguchi M, Okamoto H, Okamura T, Shibuya M. Takagi Y, et al. Among authors: nagamata m. Oncologist. 2014 Nov;19(11):1194-9. doi: 10.1634/theoncologist.2014-0221. Epub 2014 Sep 26. Oncologist. 2014. PMID: 25260366 Free PMC article. Clinical Trial.
Phase II study of oral vitamin B12 supplementation as an alternative to intramuscular injection for patients with non-small cell lung cancer undergoing pemetrexed therapy.
Takagi Y, Hosomi Y, Nagamata M, Watanabe K, Takahashi S, Nakahara Y, Yomota M, Sunami K, Okuma Y, Shimokawa T, Okamura T. Takagi Y, et al. Among authors: nagamata m. Cancer Chemother Pharmacol. 2016 Mar;77(3):559-64. doi: 10.1007/s00280-015-2954-x. Epub 2016 Jan 28. Cancer Chemother Pharmacol. 2016. PMID: 26821156 Clinical Trial.
A phase II study of nanoparticle albumin-bound paclitaxel plus carboplatin as the first-line therapy in elderly patients with previously untreated advanced non-small cell lung cancer.
Okuma Y, Hosomi Y, Takahashi S, Nakahara Y, Watanabe K, Nagamata M, Takagi Y, Mikura S. Okuma Y, et al. Among authors: nagamata m. Cancer Chemother Pharmacol. 2016 Aug;78(2):383-8. doi: 10.1007/s00280-016-3092-9. Epub 2016 Jun 23. Cancer Chemother Pharmacol. 2016. PMID: 27339149 Clinical Trial.
Phase I/II study of induction chemotherapy using carboplatin plus irinotecan and sequential thoracic radiotherapy (TRT) for elderly patients with limited-disease small-cell lung cancer (LD-SCLC): TORG 0604.
Misumi Y, Okamoto H, Sasaki J, Masuda N, Ishii M, Shimokawa T, Hosomi Y, Okuma Y, Nagamata M, Ogura T, Kato T, Sata M, Otani S, Takakura A, Minato K, Miura Y, Yokoyama T, Takata S, Naoki K, Watanabe K. Misumi Y, et al. Among authors: nagamata m. BMC Cancer. 2017 May 26;17(1):377. doi: 10.1186/s12885-017-3353-y. BMC Cancer. 2017. PMID: 28549414 Free PMC article. Clinical Trial.